Inactive Instrument
Epirus Biopharmaceuticals Inc Stock Other OTC
Stocks
US29428P1075
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 746K 659K 623K 565K 1.06M 71.61M 1.07M 7.48M 2.88M 36.57M 2.8M 2.74M 118M | P/E 2014 |
-0.83x | P/E 2015 | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | -15.94M -14.06M -13.31M -12.07M -22.62M -1.53B -22.85M -160M -61.52M -781M -59.84M -58.54M -2.51B | EV / Sales 2014 |
14,770,294,750x | EV / Sales 2015 | 83,658,631x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| 1 day | +7.14% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.14% | +7.14% | - | - | 26 | |
| -0.45% | +3.60% | +10.39% | +38.41% | 48.85B | |
| -0.73% | -0.41% | +48.84% | +36.72% | 44.28B | |
| +1.36% | +6.03% | +343.85% | +638.73% | 43.83B | |
| -0.47% | -0.76% | +9.75% | +103.07% | 41.53B | |
| +0.34% | +0.22% | +5.18% | +47.36% | 30.13B | |
| +1.00% | -1.28% | +24.23% | +156.93% | 17.36B | |
| -0.89% | -0.84% | +22.24% | +44.29% | 14.99B | |
| -2.94% | +6.98% | +5.10% | - | 14.9B | |
| -0.86% | -4.00% | - | - | 14.98B | |
| Average | +0.62% | +0.61% | +58.70% | +152.22% | 30.09B | |
| Weighted average by Cap. | -0.06% | +1.21% | +74.77% | +168.45% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.2 0.02 0.01 0.63 | 0.7 0.62 0.59 0.53 1 67.27 1.01 7.02 2.71 34.35 2.63 2.57 110.54 |
| Net income | -41.84M -36.93M -34.94M -31.69M -59.41M -4.02B -59.99M -419M -162M -2.05B -157M -154M -6.6B | -52.19M -46.06M -43.58M -39.52M -74.09M -5.01B -74.82M -523M -201M -2.56B -196M -192M -8.23B |
| Net Debt | -14.18M -12.51M -11.84M -10.74M -20.13M -1.36B -20.33M -142M -54.74M -695M -53.25M -52.09M -2.24B | -16.68M -14.72M -13.93M -12.63M -23.68M -1.6B -23.92M -167M -64.4M -817M -62.64M -61.28M -2.63B |
Employees
-
